Burcon NutraScience Corp

Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries in Canada. The firm's products include CLARISOY, a soy protein for dairy foods, neutral pH beverages, and coffee creamers and whiteners, and Peazazz, a pea protein for dairy alternative products, such as protein bars and crisps, weight management and meal replacement products, and vegetarian and vegan foods, as well as dry blended and ready-to-drink beverages. It also offers Supertein and Puratein, which are canola protein isolates for use in beverages, confectionery, aerated desserts, protein bars, baked goods, dressings, sauces, and meat substitutes. The company was founded on November 3, 1998 and is headquartered in Vancouver, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries. The firm's product categories include Pea Proteins, Canola Proteins, and Protein Blends. It offers Peazazz, Peazac, Supertein, Puratein, Nutratein, and CLARISOY. It also provides pilot plant services, which is a processing technology for large-scale production of high-purity protein. The company was founded on November 3, 1998 and is headquartered in Vancouver, Canada.

Vancouver, British Columbia--(Newsfile Corp. - May 15, 2024) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that its common shares have begun trading in the United States on the OTCQB Venture Market ("OTCQB"), under the symbol "BRCNF", effective May 8, 2024. "We are excited to announce improved access for US investors by initiating trading on the OTCQB," said Kip Underwood, Burcon's chief executive officer.

Burcon Expands US Investor Outreach with Trading on the OTCQB Venture Market Under Symbol BRCNF

Dallas, Texas--(Newsfile Corp. - April 30, 2024) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners initiates their coverage on Burcon Nutrascience Corporation (TSX: BU). To view the full announcement, including downloadable images, bios, and more, click here.

Stonegate Initiates Coverage on Burcon Nutrascience Corporation (BU)

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2024) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce the successful closing of an over-subscribed non-brokered private placement of units of the Company (the "Units") at an issue price of $0.215 per Unit for gross proceeds of $4,364,160 (the "Offering"). Principal subscribers include Company directors, management, long-term shareholders, and new investors in support of Burcon's long-term vision.

Burcon Closes Over-Subscribed $4.3 Million Non-Brokered Private Placement to Accelerate Commercial Plans

Burcon NutraScience Corporation (BRCNF) Q3 2024 Earnings Call Transcript

Vancouver, British Columbia--(Newsfile Corp. - February 14, 2024) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal third quarter ended December 31, 2023. Operational highlights for the third quarter ended December 31, 2023: During the quarter, Burcon: established commercial production capabilities via integration of proprietary processing equipment at partner manufacturer's facility; entered into production agreement with partner manufacturer; received significant interest from former Merit customers for Burcon's pea and canola proteins; entered into an agreement to access second $5 million tranche of the $10 million loan from its largest shareholder; showcased its 95% hempseed protein isolate at SupplySide West tradeshow; and received significant customer interest for its hempseed protein isolate.

Burcon Reports Fiscal 2024 Third Quarter Results

Vancouver, British Columbia--(Newsfile Corp. - January 31, 2024) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, will hold an investor conference call and webcast on Wednesday, February 14, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal third quarter ended December 31, 2023.

Burcon Announces Fiscal 2024 Third Quarter Conference Call to be Held on February 14, 2024

Vancouver, British Columbia--(Newsfile Corp. - August 14, 2023) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal first quarter ended June 30, 2023. Operational highlights for the first quarter ended June 30, 2023: During the quarter, Burcon: closed a fully subscribed $3.4 million non-brokered private placement; announced that its sunflower protein process is commercially ready; launched its Winnipeg Technical Centre as a pilot plant processing and scale-up validation service provider; expanded its scope of strategic partnership opportunities for each of its innovative plant-based protein technologies; and advanced the due diligence process to commercialize its hempseed protein technology Subsequent to the quarter-end, Burcon: partnered with HPS Food and Ingredients Inc. to launch the world's first soluble hempseed protein isolate; and successfully launched its soluble hempseed protein isolate at IFT FIRST 2023 in Chicago, IL Management Commentary Burcon began fiscal 2024 by strengthening its balance sheet with a $3.4 million non-brokered private placement, which, together with its recent cost-cutting measures and pursuit of potential government funding, is expected to provide us with sufficient runway to execute our Burcon 2.0 strategy.

Burcon Reports Fiscal 2024 First Quarter Results

Burcon NutraScience Corp (TSX:BU) has reported progress in its strategic initiatives and expressed optimism about the future, despite facing challenges, as it posted its unaudited results for the fiscal year ended March 31, 2023. In the results statement, Kip Underwood, CEO of Burcon, commented: "Fiscal 2023 was a challenging year for Burcon.

Burcon NutraScience says strategic initiatives progressing; optimistic about future

Vancouver, British Columbia--(Newsfile Corp. - June 12, 2023) - Burcon NutraScience Corporation (TSX: BU) ("Burcon or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, will hold an investor conference call and webcast on Thursday, June 22, 2023 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal year ended March 31, 2023.

Burcon Announces Fiscal Year End 2023 Conference Call to Be Held on June 22, 2023

Burcon NutraScience Corp (TSX:BU) said it is now offering pilot plant processing and scale-up validation to its partners and customers through the expansion of its protein development and innovation business. The company said at its 10,000-square-foot Winnipeg Technical Centre, including lab and pilot scale production facilities, it uses cutting-edge commercial processing equipment for end-to-end product development.

Burcon NutraScience expands offering with pilot plant processing and scale-up validation services

Burcon NutraScience Corporation said it has received additional interest in its financing and has completed the third and final tranche of its previously announced, non-brokered private placement, raising a total of $3.4 million by issuing 12,880,829 company units at a price of $0.265 per unit. The company said it intends to use the proceeds from the offering to continue its research and development program, advance its ongoing commercialization efforts, explore new routes-to-market for its commercially proven technologies and for general corporate purposes.

Burcon NutraScience closes final private placement tranche; raises $3.4M in total

Burcon NutraScience Corporation has closed the second tranche of its non-brokered private placement, raising approximately $3.3 million in gross proceeds. The company issued 3,211,424 units at a price of $0.265 per unit, bringing the total closed amount of the offering to 71%.

Burcon NutraScience closes second tranche of private placement, raises $3.3M for expansion and research

Burcon NutraScience Corp (TSX:BU) announced that it has successfully completed end-to-end validation trials of its novel sunflower protein process using commercial-scale equipment at its Winnipeg Technical Centre. The company said it has validated that its innovative sunflower protein process is robust and ready for commercial scale-up.

Burcon NutraScience reveals commercially ready sunflower protein process

Burcon NutraScience Corp (TSX:BU) said it will be raising gross proceeds of approximately $3.3 million from a fully subscribed non-brokered private placement. Long-term shareholders, including an insider, and a new investor have subscribed to the offering which the company said it believes will close in two tranches, the first on May 8, 2023, and the second on or before May 11, 2023.

Burcon NutraScience announces fully subscribed funding round

Burcon NutraScience Corp (TSX:BU) is part of a bid to acquire the assets of Merit Functional Foods, the company announced. An unnamed industry participant in association with Burcon has submitted a bid to acquire the assets, including a facility that the parties intend to restart and return to profitability.

Burcon NutraScience jumps on bid to acquire Merit Functional Foods facility

Burcon NutraScience Corp (TSX:BU)  said its bid to acquire the assets of Merit Functional Foods continues as it engages in the due diligence process. The company said it has been in discussions with the appointed receiver, PricewaterhouseCoopers Inc, LIT, about the sales process since Merit was placed into receivership on March 1, 2023.

Burcon NutraScience updates on efforts to acquire assest of Merit Functional Foods

Burcon NutraScience Corp (TSX:BU) announced that it intends to submit a formal proposal to acquire the business of Merit Functional Foods. The provider of technology for the development of plant-based proteins for foods and beverages said as co-founder of Merit, Burcon believes it is in a unique position to bring the company's business to profitability, even as Merit has been placed in receivership as of March 1, 2023.

Burcon NutraScience in talks to acquire Merit Functional Foods' business

Burcon NutraScience Corp (TSX:BU) said it has achieved another quarterly record of royalty revenues from its licensee Merit Functional Foods Corporation during the fiscal third quarter of 2023. For the three months ended December 31, 2022, the company posted royalty revenues from Merit of $161,000, up from $45,000 in the same quarter in the previous year.

Burcon Nutrascience reports quarterly record of royalty revenues from licensee Merit Functional Foods

Burcon NutraScience Corp (TSX:BU) said it has taken steps to re-assess its participation in Merit Functional Foods Corp, in which it holds a 31.6% stake, citing near-term concerns about Merit's financial situation and viability. In a letter to investors, Burcon CEO Kip Underwood told shareholders that after the company provided loans in the aggregate amount of $3 million to address Merit's anticipated liquidity requirements as it continued to ramp up its production and sales in September 2022, Merit began a process to identify a new strategic investor for its business but to-date no funding has been received.

Burcon NutraScience reiterates commitment to Merit Functional Foods business, outlines funding plans in shareholder letter

Vancouver, British Columbia--(Newsfile Corp. - February 1, 2023) - Burcon NutraScience Corporation (TSX: BU) ("Burcon or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, will hold an investor conference call and webcast on Tuesday, February 14, 2023 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal third quarter ended December 31, 2022.

Burcon Announces Fiscal 2023 Third Quarter Conference Call to be Held on February 14, 2023

Burcon NutraScience Corp (TSX:BU) has announced that it has received a Notice of Allowance from the US Patent and Trademark Office for a patent application covering characteristics of its Peazazz pea protein made by its unique process.  The company explained that a Notice of Allowance is a written notification that a patent application has cleared internal review, is pending issuance and will grant in the near future.

Burcon NutraScience receives Notice of Allowance for US patent covering key Peazazz pea protein

Burcon NutraScience Corp (TSX:BU) has announced that its joint venture company, Merit Functional Foods Corporation has launched its first US Department of Agriculture (USDA) Certified Organic protein ingredient, Organic Peazazz C 850. The developer of plant-based proteins for foods and beverages said organic pea protein ingredients are currently in high demand and in short supply.

Burcon NutraScience joint venture Merit Functional Foods launches new organic pea protein

Burcon NutraScience Corporation has announced that Aaron Ratner was elected to its board of directors at the company's annual general meeting held on November 23. The developer of plant-based proteins for foods and beverages said Ratner has over 20 years of domestic and international investment and advisory experience, including eight years in Asia, focusing on project finance, venture capital, climate technology, energy, and agriculture.

Burcon NutraScience elects climate tech specialist Aaron Ratner to its board of directors

Burcon NutraScience Corp (TSX:BU), a global technology leader in the development of plant-based proteins for foods and beverages, has reported results for its fiscal second quarter ended September 30, 2022.  During the quarter, Burcon recorded royalty revenues from its 31.6% licensee, Merit Functional Foods Corporation of $112,000, compared to $32,000 in the same year-ago quarter.

Burcon NutraScience reports 24% rise in royalty revenue in Q2 from investee company Merit Functional Foods

Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Burcon NutraScience Corporation (TSX: BU) ("Burcon or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal second quarter ended September 30, 2022.

News for Burcon NutraScience Corp Stock (BRCNF)